Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- University of Cambridge;
- Autonomous University of Madrid (Universidad Autónoma de Madrid)
- Fundacio de Recerca Clinic Barcelona-Institut d'Investigacions Biomediques August Pi i Sunyer
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- IBIMA Plataforma BIONAND
- Johannes Gutenberg University Mainz •
- Purdue University
- SciLifeLab
- The Ohio State University
- The University of Chicago
- University of Basel
- University of Birmingham
- University of Gdansk
- University of Mainz
- Université Paris Cité
- 6 more »
- « less
-
Field
-
Your position Despite the success of EBV-specific T-cell therapies in selected malignancies, therapeutic efficacy remains limited in tumors expressing only a restricted repertoire of viral antigens. This project aims to identify novel tumor-reactive T-cell receptors (TCRs) that can be translated...
-
German Cancer Research Center in the Helmholtz Association (DKFZ) | Oettingen in Bayern, Bayern | Germany | 3 months ago
, the German Cancer Research Center is seeking, as of October 2026, a PhD Candidate focusing on "Molecular resolution imaging of immunotherapy target receptors in multiple myeloma" Reference number: 2026-0127
-
cancers worldwide despite major advances in immunotherapy. A major obstacle is the profound immunosuppressive tumor microenvironment that progressively disables anti-tumor immune responses. Natural Killer
-
/halim-group/ The immune system is capable of detecting cancer, which forms the basis of immunotherapy. While immunotherapy has revolutionised cancer treatment in recent years, it remains unclear how
-
benefit while sparing those unlikely to respond from their toxicities remains a major challenge. Many modern therapies, like immunotherapy and ADCs, rely on tissue architecture to be effective
-
Fundacio de Recerca Clinic Barcelona-Institut d'Investigacions Biomediques August Pi i Sunyer | Spain | 5 days ago
hepatic oncology, Josep M. Llovet Project: Characterization and Impact of Intratumoral and Gut Microbiome on Immunotherapy Response in Hepatocellular Carcinoma Desirable criteria: Laboratory Experience
-
dependencies in cell and primary patient models. Jointly supervised by Dr. Tianyi Zhang and Professors Guy Pratt and Sarah Dimeloe who will provide supervision in genome biology, immunology and immunotherapy and
-
-Oncology by leading projects aimed at developing therapeutic strategies that enhance innate immunity against cancers that are refractory to immunotherapy. The appointees will be expected to build internal
-
the guidance of Dr. Acharya, the Researcher 2 will conduct specialized research aimed at identifying novel therapeutics that can synergize with existing immunotherapy modalities. The Researcher 2 will
-
their commercialization and implementation into clinical practice. ICCVS works on a range of national and international research projects concentrating on cancer biology and novel approaches to immunotherapies. The focus